Clinical Trials | June 09, 2026
AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations
The company will present 21 oral and poster presentations spanning investigational and approved therapies
The company will present 21 oral and poster presentations spanning investigational and approved therapies
The safety profile was described as manageable, though not without notable toxicities
The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes
With standout ADC and t-cell engager response data across hard-to-treat cancers
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
The precision health platform integrates genetics, biomarkers, diet, and lifestyle data to deliver personalised gut health interventions and therapy support
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
